Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI ( (CLBT) ) has provided an update.
Cellebrite DI Ltd. has released its unaudited consolidated financial statements for the six months ending June 30, 2025, showing a significant increase in total revenue to $220.8 million compared to $185.3 million in the same period last year. This financial growth reflects the company’s strengthened market position and its successful expansion in subscription services, which saw a notable rise in revenue, indicating a positive impact on its operations and stakeholder confidence.
The most recent analyst rating on (CLBT) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.
Cellebrite DI’s overall stock score is driven primarily by strong financial performance and positive earnings call highlights. However, technical analysis shows bearish signals, and valuation is impacted by net losses and the absence of a dividend yield. The company’s growth outlook is positive, but current net profitability challenges and market technicals moderate the overall score.
To see Spark’s full report on CLBT stock, click here.
More about Cellebrite DI
Cellebrite DI Ltd. operates in the digital intelligence industry, providing solutions for digital forensics, data extraction, and analysis. The company focuses on serving law enforcement, government agencies, and enterprises globally with its advanced technology for digital investigations.
Average Trading Volume: 1,510,068
Technical Sentiment Signal: Hold
Current Market Cap: $3.33B
See more insights into CLBT stock on TipRanks’ Stock Analysis page.